Form 4: Eli Lilly Executive Diogo Rau Reports Stock Transactions
SEC Form 4 Filing
Eli Lilly's Executive Vice President and Chief Information and Digital Officer, Diogo Rau, reported the acquisition of 6,300 shares of common stock through the vesting of restricted stock units and the disposition of 3,045 shares to cover tax obligations.
Summary
- Diogo Rau, an Executive Vice President and Chief Information and Digital Officer at Eli Lilly, reported transactions involving the company's common stock.
- On June 1, 2024, Rau acquired 6,300 shares of common stock through the vesting of restricted stock units.
- Also on June 1, 2024, Rau disposed of 3,045 shares of common stock at a price of $820.34 per share to cover tax obligations.
- Following these transactions, Rau directly owns 11,101 shares of Eli Lilly common stock.
Sentiment
Score: 7
Explanation: The document reflects standard executive stock transactions, which are neither particularly positive nor negative. The vesting of stock units is a positive sign of compensation, while the sale is a normal part of the process.
Positives
- The vesting of restricted stock units indicates a form of compensation and alignment of interests between the executive and the company's performance.
Negatives
- The sale of 3,045 shares, while likely for tax purposes, could be perceived as a slight reduction in the executive's direct stake in the company.
Risks
- There are no specific risks mentioned in this document, as it primarily details stock transactions by an executive.
Industry Context
This is a routine filing related to executive compensation and stock transactions, which is common in publicly traded companies like Eli Lilly. It does not indicate any specific industry trend or competitive activity.
Comparison to Industry Standards
- Executive stock transactions are a standard practice in publicly traded companies, including pharmaceutical giants like Pfizer (PFE), Johnson & Johnson (JNJ), and Merck (MRK).
- The vesting of restricted stock units is a common form of executive compensation, aligning executive interests with company performance.
- The sale of shares to cover tax obligations is also a typical occurrence after vesting events.
Stakeholder Impact
- The transactions have a minor impact on shareholders, as they reflect routine executive compensation and tax-related sales.
- The vesting of stock units can be seen as a positive sign of alignment between executive interests and company performance.
Key Dates
| Date | Description |
|---|---|
| 06/01/2022 | 7,560 restricted stock units vested. |
| 06/01/2023 | 6,300 restricted stock units vested. |
| 06/01/2024 | 6,300 restricted stock units vested and 3,045 shares sold for tax obligations. |
| 06/04/2024 | Date of filing the Form 4. |
Keywords
Eli Lilly, LLY, Diogo Rau, stock transaction, restricted stock units, executive compensation, insider trading, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.